Digital health & care delivery · Chronic disease concierge care
Gradia Health
A software layer that lets brick and mortar clinics run virtual care teams, dietitians and nurses, for chronic condition patients between visits. Backed by a $4.2 million seed round announced in July 2023, though the public record does not agree on total raised or even where it is based.
Two Stanford dropouts and a lot of clinic hours
Rithvik Seela and Andrew Zelaya met studying computer science at Stanford. Before they built anything, they spent time inside actual clinics. “My co-founder, Andrew Zelaya, and I started Gradia while attending Stanford. During our time there, we studied computer science and, by that point, had spent thousands of hours in clinics for personal reasons,” Seela told Pulse 2.0 in 2023.
The pair left school to build the company. “We quickly realized that patient care needed to be more cohesive and extend far beyond the typically brief clinic appointment,” Seela said, describing months spent working free in clinics, learning how physician incentives worked. Zelaya, per his personal site, was born in Miami, Florida, and dropped out of Stanford’s computer science program.
The gap: care that stops at the clinic door
Gradia’s pitch rests on a specific complaint about American primary and specialty care: a patient with a chronic condition sees a physician for a few minutes every few months, and gets little support in between. The company’s own about page puts it this way, describing a system where “physicians are spread too thin and patients lack the low latency, holistic care needed to improve.”
Gradia’s answer is software that clinics use to stand up a virtual care team, dietitians and nurses who work with patients by phone, message or video between in person visits. The company has said its early customers were multi provider clinics serving patients with chronic gastrointestinal conditions. “Gradia partners with several multi-provider clinics that serve thousands of the 60-70 million Americans who have chronic GI conditions, including IBS, GERD, fatty liver, and more,” Seela told Pulse 2.0 in the same 2023 interview, describing the company’s addressable market. By late 2025, Forbes described the company’s focus somewhat differently: “With Gradia Health, Zelaya and Seela have developed software to give Medicare patients with chronic illnesses customized support, such as access to virtual nurses and dieticians, helping to support brick and mortar clinics in between in-person appointments.” That description points at Medicare beneficiaries broadly rather than the GI focused, multi provider clinic base described in 2023, and no source reviewed for this profile explains the shift or names which payers cover Gradia’s services.
From Y Combinator to a $4.2 million seed
Gradia went through Y Combinator’s Winter 2021 batch. PitchBook logs a $125,000 accelerator investment dated January 1, 2021, the standard size of a YC check at the time, and a second, undisclosed seed round in July 2022. Neither of those earlier rounds appears to have been announced in the press at the time.
The round that did get announced came on July 12, 2023: a $4.2 million seed led by Adrian Fenty at MaC Venture Capital, with Y Combinator, Soma Capital, Atlanta Ventures and named angels including Gene Lee of Ramp, Eric Feldman of Bolt and David Tsao of BillionToOne. The release, carried by Businesswire, said the money would go toward scaling the platform, growing the team and refining care pathways with physicians. It was syndicated by FinSMEs, Healthcare IT Today, Pulse 2.0, thebiostartups.com and VC News Daily, and separately confirmed by Healthcare Services Investment News, an independent deal tracking newsletter, citing Fortune’s Term Sheet.
Fenty, the round’s lead investor, framed the bet this way in the announcement: “Gradia is changing the healthcare landscape and taking a hands-on approach to provide patients with the proper attention they need once they leave the clinic.”
What has and has not been confirmed since
Since the 2023 seed, the public record thins out. GetLatka put Gradia’s 2024 revenue at an estimated $1.1 million and its team at 7 people, both labeled as estimates. LinkedIn lists 2 to 10 employees and 1,584 followers as of this writing. In December 2025, Forbes named Seela and Zelaya to its 30 Under 30 Finance list for 2026, crediting them with the Medicare focused software described above and putting total raised at $5.8 million, a figure that matches neither the $4.2 million headline nor PitchBook’s $6.83 million tally. No later funding round, acquisition or shutdown was found in any source checked for this profile.
What is proven, and what is still claimed
| Evidence | What the record shows | Source type |
|---|---|---|
| Y Combinator batch | Winter 2021, per Y Combinator’s own company page. PitchBook separately logs a $125,000 accelerator investment dated Jan 1, 2021. | Independent |
| Seed funding, announced | $4.2 million, announced Jul 12, 2023, led by MaC Venture Capital with Y Combinator, Soma Capital, Atlanta Ventures and named angels. Reported the same week by Businesswire, FinSMEs, Pulse 2.0, Healthcare IT Today, VC News Daily and Healthcare Services Investment News. | Independent |
| Total capital raised, three different numbers | Company and press describe one $4.2 million seed round. Forbes’ December 2025 profile puts total raised at $5.8 million. PitchBook logs three rounds, an accelerator check, an undisclosed Jul 2022 seed and the Jul 2023 seed, totaling $6.83 million. Nothing found reconciles the figures. | Differs across sources |
| Headquarters | Businesswire, FinSMEs and the company’s LinkedIn page list San Francisco, CA. Y Combinator lists New York City, NY. PitchBook and Tracxn list Orlando, FL, matching VC News Daily’s Orlando dateline on the funding story. | Differs across sources |
| Year founded | 2021 per the company, Y Combinator, Businesswire and LinkedIn. Tracxn lists 2020. | Differs across sources |
| Federal and public records | No FDA 510(k), PMA, trial, NIH award, NSF award, PubMed listing, or SEC Form D filing was matched to Gradia Health. | Not found |
| 2024 revenue | GetLatka estimates $1.1 million in annual revenue for 2024, labeled on the site as its own estimate rather than a disclosed figure. | Estimate |
| Third party product listing | SaaSworthy lists a Palo Alto, CA vendor address and a gradiahealth.com domain, describing SMS based visit reminders and a 97% satisfaction figure, details not found elsewhere and not matching the company’s own description of dietitian and nurse care teams. | Differs from company account |
Read plainly: the core story, that Seela and Zelaya left Stanford in 2021, went through Y Combinator, and raised a $4.2 million seed in 2023 led by MaC Venture Capital, is consistent across the company’s materials and independent coverage. What is not consistent is anything measured since: total money raised, headquarters, even which patients it primarily serves. No FDA record, trial or federal grant ties to the company, fitting a software business rather than a device maker, but also leaving no regulatory record to check its claims against.
What to watch
- Whether Gradia clarifies the total amount raised, given three different public figures.
- Confirmation of the company’s actual headquarters, given conflicting listings in San Francisco, Orlando and New York City.
- Any named payer contracts or Medicare specific program details following Forbes’ December 2025 description of the patient population.
- A new funding announcement, given the last confirmed press release dates to July 2023.
In their words
“My co-founder, Andrew Zelaya, and I started Gradia while attending Stanford. During our time there, we studied computer science and, by that point, had spent thousands of hours in clinics for personal reasons.”
Rithvik Seela, co-founder and CEO, Pulse 2.0 interview, 2023 · Interview
“We quickly realized that patient care needed to be more cohesive and extend far beyond the typically brief clinic appointment.”
Rithvik Seela, Pulse 2.0 interview, 2023 · Interview
“Gradia partners with several multi-provider clinics that serve thousands of the 60-70 million Americans who have chronic GI conditions, including IBS, GERD, fatty liver, and more.”
Rithvik Seela, Pulse 2.0 interview, 2023 · Interview
“Our vision is to extend physicians’ capabilities and empower them to deliver a superior, continuous care experience that every patient not only needs but also deserves.”
Rithvik Seela, seed funding release, Jul 12, 2023 · Company release
“Gradia is changing the healthcare landscape and taking a hands-on approach to provide patients with the proper attention they need once they leave the clinic.”
Adrian Fenty, General Partner, MaC Venture Capital, quoted in the Jul 12, 2023 release · Company release
“With Gradia Health, Zelaya and Seela have developed software to give Medicare patients with chronic illnesses customized support, such as access to virtual nurses and dieticians, helping to support brick and mortar clinics in between in-person appointments.”
Forbes, 30 Under 30 Finance 2026 profile, Dec 2, 2025 · Independent
Related companies
Sources
- CompanyGradia Health about page
- CompanyGradia Health homepage, archived capture
- IndependentGradia Health company page
- InterviewGradia Health: This Concierge Care Platform Helps Clinics Serve Patients With Chronic Conditions Better
- CompanyGradia Health Secures $4.2M in Seed Funding to Improve Ongoing Care for Patients With Chronic Conditions
- IndependentGradia Health Secures $4.2M in Seed Funding to Improve Ongoing Care for Patients with Chronic Conditions
- IndependentGradia Health: Integrated Concierge Care Platform Closes $4.2 Million In Funding
- IndependentGradia Health Raises $4.2M in Seed Funding
- IndependentGradia Health Raises $4.2M in Seed Funding
- IndependentGradia Health Claims $4.2M Seed Round
- IndependentGradia Health Seed Round Nets $4.2M
- CompanyGradia Health portfolio page
- IndependentGradia Health 2026 Company Profile
- IndependentGradia - 2026 Company Profile, Team, Funding & Competitors
- IndependentGradia Health Revenue 2024: $1.1M Est. ARR
- IndependentGradia Health, 30 Under 30 Finance 2026 profile
- IndependentGradia Health listing
- CompanyGradia Health company page
- CompanyAndrew Zelaya personal site
Profile researched and written by Healthcare Discovery. Last updated September 29, 2026.
